Article citationsMore>>

Huang, J., Xu, J.M., Chen, Y., et al. (2020) Camrelizumab Versus Investigator’s Choice of Chemotherapy as Second-Line Therapy for Advanced or Metastatic Oesophageal Squamous Cell Carcinoma (ESCORT): A Multicentre, Randomised, Open-Label, Phase 3 Study. The Lancet Oncology, 21, 832-842.
https://doi.org/10.1016/S1470-2045(20)30110-8

has been cited by the following article:

• TITLE: A Case of Target Immunotherapy Combined with Interventional Therapy for Massive Liver Cancer

  AUTHORS: Ruidong Zhao, Xiang Zheng

  KEYWORDS: Hepatocellular Carcinoma, Targeted Therapy, Immunotherapy, Interventional Therapy

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.2, February 22, 2023

  ABSTRACT: This article reports a case of massive hepatocellular carcinoma. After intervention combined with targeted and immunotherapy, it was successfully cured by surgical resection, which provides some experience for the comprehensive treatment of liver cancer, and also improves the understanding of systematic treatment of liver cancer, so as to improve the understanding and diagnosis of the disease.